Skip to content

Dr. Govarts Anouk

Active
Private limited companyfounded 2023active for 2 yearsGoede Weide 14, 3270 Scherpenheuvel-Zichem, BelgiumKBO/BCE: BE 1003.451.142
Summary

Dr. Govarts Anouk has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €155,696 and a net result of €52,576. Its solvency ranks better than 76% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dr. Govarts AnoukActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Activity
General medical practice
NACE 86210
1 site
Size
≈ €150,000turnover 2025, estimated
Equity
€155,696
Profit
€52,576
Turnover estimated from the gross margin
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts filed 31 days late
Why 98lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.15, cash €167,832Equity €155,696 (84.2% of total assets)Size: total assets €184,986Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 82% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 84.2% of total assets
Liquidity 96-1
short-term debt 15.8% · cash 90.7%
Profitability 100=
return on assets 28.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 01-2025: 0.3% 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.1 percentage points vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025highest value 09-2025: < 0.1%▼ -0.4 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €15,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 6.15, compared with 6.61 in 2024, above the usual 1.5; short-term debt: 15.8% and cash: 90.7% of total assets), and 15.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 84% on liquidity, 80% on profitability and 80% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.15, cash €167,832
NBB · annual accounts
lowers risk · Equity €155,696 (84.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €184,986
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Young company
Founded in 2023, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
31 days late
2024
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 16 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €150,000equity €155,696 ▲51%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Equity rose in 2025from €103,121 to €155,696 ▲ 51.0% View
  • One director decidessole director in office 1 View
  • Total assets 20252 financial years filed €184,986 View

By topic

Financials

Financial year
2025
Total assets
€184,986
Profit
€52,576
Solvency
84.2%
Total assets▲ 53.4%
Net result
20242025
Go to Financials

Timeline

Events
4
Since
2023
Next accounts
by 31-07-2027
  1. 19-12-2023Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
15-12-2023
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Dr. Govarts Anouk

What is the company number of Dr. Govarts Anouk?
1003.451.142. In Belgium the VAT number is the company number with BE in front: BE 1003.451.142.
Where is Dr. Govarts Anouk based?
The registered office is at Goede Weide 14, 3270 Scherpenheuvel-Zichem.Company details
What does Dr. Govarts Anouk do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Govarts Anouk?
Private limited company (BV).
When was Dr. Govarts Anouk founded?
On 15-12-2023.
Is Dr. Govarts Anouk still active?
Yes, Dr. Govarts Anouk is an active enterprise in the KBO register.
What is the turnover of Dr. Govarts Anouk?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Govarts Anouk profitable?
In financial year 2025, Dr. Govarts Anouk made a profit of €52,576.
Where can I find the annual accounts of Dr. Govarts Anouk?
Dr. Govarts Anouk filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Govarts Anouk due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Dr. Govarts Anouk

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure